APO Research
Talk to an analyst

APO RESEARCH · REPORT

Modified Proteomics Service

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Modified Proteomics Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

12 August 2026195 pages

Choose your research edition.

Industry ResearchModified Proteomics Service Industry Research Report 2026139 pages · $2,950 USDIndustry Growth & TrendsGlobal Modified Proteomics Service Industry Growth and Trends Forecast to 2032122 pages · $3,450 USDMarket StructureGlobal Modified Proteomics Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Modified Proteomics Service Market Outlook and Growth Opportunities 2026210 pages · $4,250 USDMarket Analysis & ForecastGlobal Modified Proteomics Service Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Modified Proteomics Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Modified Proteomics Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Modified Proteomics Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Modified Proteomics Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Modified Proteomics Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Modified Proteomics Service include BGI Genomics, OmicScouts (Momentum Biotechnologies), Biodesix, Shanghai OE Biotech, Crown Bioscience, Shanghai Bioprofile, Creative Proteomics, Inotiv and MtoZ-Biolabs, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Modified Proteomics Service market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Modified Proteomics Service and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Modified Proteomics Service revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Modified Proteomics Service market size, projected growth trends, production technologies, key applications, and end-use industries.

Modified Proteomics Service Segment by Company

BGI Genomics

OmicScouts (Momentum Biotechnologies)

Biodesix

Shanghai OE Biotech

Crown Bioscience

Shanghai Bioprofile

Creative Proteomics

Inotiv

MtoZ-Biolabs

CellCarta

Biognosys

MS Bioworks

Charles River Laboratories

Metware Biotechnology

Novogene

Evotec

RxCelerate

Shanghai Majorbio Bio-Pharm

Lc-Bio Technologies

CD Genomics

Discovery Life Sciences

Applied Biomics

VProteomics

Allumiqs

Westlake Omics

CDI Labs

Proteome Sciences

Sapient Bioanalytics

Proteomics International

Cosmos Wisdom

MRM Proteomics

Sinotech Genomics

Precision Biomarker Laboratories (PBL)

PTM BIO

Cell Signaling Technology (CST)

APTBIO

Modified Proteomics Service Segment by Type

Phosphorylation

Acetylation

Ubiquitination

Methylation

Glycosylation

Lactylation

Redox

Palmitoylation

Others

Modified Proteomics Service Segment by Application

Clinical Diagnostics

Drug Discovery

Others

Modified Proteomics Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Modified Proteomics Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Modified Proteomics Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Modified Proteomics Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Modified Proteomics Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Modified Proteomics Service industry.

Chapter 3: Detailed analysis of Modified Proteomics Service companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Modified Proteomics Servicerevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Modified Proteomics Service Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Phosphorylation Table 3. Key Players of Acetylation Table 4. Key Players of Ubiquitination Table 3. Key Players of Methylation Table 4. Key Players of Glycosylation Table 5. Key Players of Lactylation Table 6. Key Players of Redox Table 7. Key Players of Palmitoylation Table 8. Key Players of Others Table 9. Global Modified Proteomics Service Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 10. Key Players of Clinical Diagnostics Table 11. Key Players of Drug Discovery Table 12. Key Players of Others Table 13. Global Modified Proteomics Service Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Modified Proteomics Service Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Modified Proteomics Service Market Share by Region (2021-2026) Table 16. Global Modified Proteomics Service Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Modified Proteomics Service Market Share by Region (2027-2032) Table 18. Modified Proteomics Service Industry Trends Table 19. Modified Proteomics Service Industry Drivers Table 20. Modified Proteomics Service Industry Opportunities and Challenges Table 21. Modified Proteomics Service Industry Restraints Table 22. Global Modified Proteomics Service Revenue by Company (US$ Million) & (2021-2026) Table 23. Global Modified Proteomics Service Revenue Market Share by Company (2021-2026) Table 24. Global Modified Proteomics Service Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 25. Global Modified Proteomics Service Key Company Head Office and Area Served Table 26. Global Modified Proteomics Service Company, Product Type & Application Table 27. Global Modified Proteomics Service Company Establishment Date Table 28. Global Company Market Concentration Ratio (CR5 and HHI) Table 29. Global Modified Proteomics Service by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 30. Global Modified Proteomics Service Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Modified Proteomics Service Market Size by Type (2021-2026) & (US$ Million) Table 32. Global Modified Proteomics Service Market Size by Type (2027-2032) & (US$ Million) Table 33. Global Modified Proteomics Service Revenue Market Share by Type (2021-2026) Table 34. Global Modified Proteomics Service Revenue Market Share by Type (2027-2032) Table 35. Global Modified Proteomics Service Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Modified Proteomics Service Market Size by Application (2021-2026) & (US$ Million) Table 37. Global Modified Proteomics Service Market Size by Application (2027-2032) & (US$ Million) Table 38. Global Modified Proteomics Service Revenue Market Share by Application (2021-2026) Table 39. Global Modified Proteomics Service Revenue Market Share by Application (2027-2032) Table 40. BGI Genomics Company Information Table 41. BGI Genomics Business Overview Table 42. BGI Genomics Modified Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. BGI Genomics Modified Proteomics Service Product Portfolio Table 44. BGI Genomics Recent Development Table 45. OmicScouts (Momentum Biotechnologies) Company Information Table 46. OmicScouts (Momentum Biotechnologies) Business Overview Table 47. OmicScouts (Momentum Biotechnologies) Modified Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. OmicScouts (Momentum Biotechnologies) Modified Proteomics Service Product Portfolio Table 49. OmicScouts (Momentum Biotechnologies) Recent Development Table 50. Biodesix Company Information Table 51. Biodesix Business Overview Table 52. Biodesix Modified Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Biodesix Modified Proteomics Service Product Portfolio Table 54. Biodesix Recent Development Table 55. Shanghai OE Biotech Company Information Table 56. Shanghai OE Biotech Business Overview Table 57. Shanghai OE Biotech Modified Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Shanghai OE Biotech Modified Proteomics Service Product Portfolio Table 59. Shanghai OE Biotech Recent Development Table 60. Crown Bioscience Company Information Table 61. Crown Bioscience Business Overview Table 62. Crown Bioscience Modified Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Crown Bioscience Modified Proteomics Service Product Portfolio Table 64. Crown Bioscience Recent Development Table 65. Shanghai Bioprofile Company Information Table 66. Shanghai Bioprofile Business Overview Table 67. Shanghai Bioprofile Modified Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Shanghai Bioprofile Modified Proteomics Service Product Portfolio Table 69. Shanghai Bioprofile Recent Development Table 70. Creative Proteomics Company Information Table 71. Creative Proteomics Business Overview Table 72. Creative Proteomics Modified Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Creative Proteomics Modified Proteomics Service Product Portfolio Table 74. Creative Proteomics Recent Development Table 75. Inotiv Company Information Table 76. Inotiv Business Overview Table 77. Inotiv Modified Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Inotiv Modified Proteomics Service Product Portfolio Table 79. Inotiv Recent Development Table 80. MtoZ-Biolabs Company Information Table 81. MtoZ-Biolabs Business Overview Table 82. MtoZ-Biolabs Modified Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. MtoZ-Biolabs Modified Proteomics Service Product Portfolio Table 84. MtoZ-Biolabs Recent Development Table 85. CellCarta Company Information Table 86. CellCarta Business Overview Table 87. CellCarta Modified Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 88. CellCarta Modified Proteomics Service Product Portfolio Table 89. CellCarta Recent Development Table 90. Biognosys Company Information Table 91. Biognosys Business Overview Table 92. Biognosys Modified Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 93. Biognosys Modified Proteomics Service Product Portfolio Table 94. Biognosys Recent Development Table 95. MS Bioworks Company Information Table 96. MS Bioworks Business Overview Table 97. MS Bioworks Modified Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 98. MS Bioworks Modified Proteomics Service Product Portfolio Table 99. MS Bioworks Recent Development Table 100. Charles River Laboratories Company Information Table 101. Charles River Laboratories Business Overview Table 102. Charles River Laboratories Modified Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 103. Charles River Laboratories Modified Proteomics Service Product Portfolio Table 104. Charles River Laboratories Recent Development Table 105. Metware Biotechnology Company Information Table 106. Metware Biotechnology Business Overview Table 107. Metware Biotechnology Modified Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 108. Metware Biotechnology Modified Proteomics Service Product Portfolio Table 109. Metware Biotechnology Recent Development Table 110. Novogene Company Information Table 111. Novogene Business Overview Table 112. Novogene Modified Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 113. Novogene Modified Proteomics Service Product Portfolio Table 114. Novogene Recent Development Table 115. Evotec Company Information Table 116. Evotec Business Overview Table 117. Evotec Modified Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 118. Evotec Modified Proteomics Service Product Portfolio Table 119. Evotec Recent Development Table 120. RxCelerate Company Information Table 121. RxCelerate Business Overview Table 122. RxCelerate Modified Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 123. RxCelerate Modified Proteomics Service Product Portfolio Table 124. RxCelerate Recent Development Table 125. Shanghai Majorbio Bio-Pharm Company Information Table 126. Shanghai Majorbio Bio-Pharm Business Overview Table 127. Shanghai Majorbio Bio-Pharm Modified Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 128. Shanghai Majorbio Bio-Pharm Modified Proteomics Service Product Portfolio Table 129. Shanghai Majorbio Bio-Pharm Recent Development Table 130. Lc-Bio Technologies Company Information Table 131. Lc-Bio Technologies Business Overview Table 132. Lc-Bio Technologies Modified Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 133. Lc-Bio Technologies Modified Proteomics Service Product Portfolio Table 134. Lc-Bio Technologies Recent Development Table 135. CD Genomics Company Information Table 136. CD Genomics Business Overview Table 137. CD Genomics Modified Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 138. CD Genomics Modified Proteomics Service Product Portfolio Table 139. CD Genomics Recent Development Table 140. Discovery Life Sciences Company Information Table 141. Discovery Life Sciences Business Overview Table 142. Discovery Life Sciences Modified Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 143. Discovery Life Sciences Modified Proteomics Service Product Portfolio Table 144. Discovery Life Sciences Recent Development Table 145. Applied Biomics Company Information Table 146. Applied Biomics Business Overview Table 147. Applied Biomics Modified Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 148. Applied Biomics Modified Proteomics Service Product Portfolio Table 149. Applied Biomics Recent Development Table 150. VProteomics Company Information Table 151. VProteomics Business Overview Table 152. VProteomics Modified Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 153. VProteomics Modified Proteomics Service Product Portfolio Table 154. VProteomics Recent Development Table 155. Allumiqs Company Information Table 156. Allumiqs Business Overview Table 157. Allumiqs Modified Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 158. Allumiqs Modified Proteomics Service Product Portfolio Table 159. Allumiqs Recent Development Table 160. Westlake Omics Company Information Table 161. Westlake Omics Business Overview Table 162. Westlake Omics Modified Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 163. Westlake Omics Modified Proteomics Service Product Portfolio Table 164. Westlake Omics Recent Development Table 165. CDI Labs Company Information Table 166. CDI Labs Business Overview Table 167. CDI Labs Modified Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 168. CDI Labs Modified Proteomics Service Product Portfolio Table 169. CDI Labs Recent Development Table 170. Proteome Sciences Company Information Table 171. Proteome Sciences Business Overview Table 172. Proteome Sciences Modified Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 173. Proteome Sciences Modified Proteomics Service Product Portfolio Table 174. Proteome Sciences Recent Development Table 175. Sapient Bioanalytics Company Information Table 176. Sapient Bioanalytics Business Overview Table 177. Sapient Bioanalytics Modified Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 178. Sapient Bioanalytics Modified Proteomics Service Product Portfolio Table 179. Sapient Bioanalytics Recent Development Table 180. Proteomics International Company Information Table 181. Proteomics International Business Overview Table 182. Proteomics International Modified Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 183. Proteomics International Modified Proteomics Service Product Portfolio Table 184. Proteomics International Recent Development Table 185. Cosmos Wisdom Company Information Table 186. Cosmos Wisdom Business Overview Table 187. Cosmos Wisdom Modified Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 188. Cosmos Wisdom Modified Proteomics Service Product Portfolio Table 189. Cosmos Wisdom Recent Development Table 190. MRM Proteomics Company Information Table 191. MRM Proteomics Business Overview Table 192. MRM Proteomics Modified Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 193. MRM Proteomics Modified Proteomics Service Product Portfolio Table 194. MRM Proteomics Recent Development Table 195. Sinotech Genomics Company Information Table 196. Sinotech Genomics Business Overview Table 197. Sinotech Genomics Modified Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 198. Sinotech Genomics Modified Proteomics Service Product Portfolio Table 199. Sinotech Genomics Recent Development Table 200. Precision Biomarker Laboratories (PBL) Company Information Table 201. Precision Biomarker Laboratories (PBL) Business Overview Table 202. Precision Biomarker Laboratories (PBL) Modified Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 203. Precision Biomarker Laboratories (PBL) Modified Proteomics Service Product Portfolio Table 204. Precision Biomarker Laboratories (PBL) Recent Development Table 205. PTM BIO Company Information Table 206. PTM BIO Business Overview Table 207. PTM BIO Modified Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 208. PTM BIO Modified Proteomics Service Product Portfolio Table 209. PTM BIO Recent Development Table 210. Cell Signaling Technology (CST) Company Information Table 211. Cell Signaling Technology (CST) Business Overview Table 212. Cell Signaling Technology (CST) Modified Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 213. Cell Signaling Technology (CST) Modified Proteomics Service Product Portfolio Table 214. Cell Signaling Technology (CST) Recent Development Table 215. APTBIO Company Information Table 216. APTBIO Business Overview Table 217. APTBIO Modified Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 218. APTBIO Modified Proteomics Service Product Portfolio Table 219. APTBIO Recent Development Table 220. North America Modified Proteomics Service Market Size by Type (2021-2026) & (US$ Million) Table 221. North America Modified Proteomics Service Market Size by Type (2027-2032) & (US$ Million) Table 222. North America Modified Proteomics Service Market Size by Application (2021-2026) & (US$ Million) Table 223. North America Modified Proteomics Service Market Size by Application (2027-2032) & (US$ Million) Table 224. North America Modified Proteomics Service Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 225. North America Modified Proteomics Service Market Size by Country (2021-2026) Table 226. North America Modified Proteomics Service Market Size by Country (2027-2032) Table 227. Europe Modified Proteomics Service Market Size by Type (2021-2026) & (US$ Million) Table 228. Europe Modified Proteomics Service Market Size by Type (2027-2032) & (US$ Million) Table 229. Europe Modified Proteomics Service Market Size by Application (2021-2026) & (US$ Million) Table 230. Europe Modified Proteomics Service Market Size by Application (2027-2032) & (US$ Million) Table 231. Europe Modified Proteomics Service Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 232. Europe Modified Proteomics Service Market Size by Country (2021-2026) Table 233. Europe Modified Proteomics Service Market Size by Country (2027-2032) Table 234. China Modified Proteomics Service Market Size by Type (2021-2026) & (US$ Million) Table 235. China Modified Proteomics Service Market Size by Type (2027-2032) & (US$ Million) Table 236. China Modified Proteomics Service Market Size by Application (2021-2026) & (US$ Million) Table 237. China Modified Proteomics Service Market Size by Application (2027-2032) & (US$ Million) Table 238. Asia Modified Proteomics Service Market Size by Type (2021-2026) & (US$ Million) Table 239. Asia Modified Proteomics Service Market Size by Type (2027-2032) & (US$ Million) Table 240. Asia Modified Proteomics Service Market Size by Application (2021-2026) & (US$ Million) Table 241. Asia Modified Proteomics Service Market Size by Application (2027-2032) & (US$ Million) Table 242. Asia Modified Proteomics Service Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 243. Asia Modified Proteomics Service Market Size by Country (2021-2026) Table 244. Asia Modified Proteomics Service Market Size by Country (2027-2032) Table 245. South America, Middle East & Africa Modified Proteomics Service Market Size by Type (2021-2026) & (US$ Million) Table 246. South America, Middle East & Africa Modified Proteomics Service Market Size by Type (2027-2032) & (US$ Million) Table 247. South America, Middle East & Africa Modified Proteomics Service Market Size by Application (2021-2026) & (US$ Million) Table 248. South America, Middle East & Africa Modified Proteomics Service Market Size by Application (2027-2032) & (US$ Million) Table 249. South America, Middle East & Africa Modified Proteomics Service Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 250. South America, Middle East & Africa Modified Proteomics Service Market Size by Country (2021-2026) Table 251. South America, Middle East & Africa Modified Proteomics Service Market Size by Country (2027-2032) Table 252. Research Programs/Design for This Report Table 253. Authors List of This Report Table 254. Secondary Sources Table 255. Primary Sources List of Figures Figure 1. Modified Proteomics Service Product Image Figure 2. Global Modified Proteomics Service Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Modified Proteomics Service Market Share by Type: 2025 VS 2032 Figure 4. Phosphorylation Image Figure 5. Acetylation Image Figure 6. Ubiquitination Image Figure 7. Methylation Image Figure 8. Glycosylation Image Figure 9. Lactylation Image Figure 10. Redox Image Figure 11. Palmitoylation Image Figure 12. Others Image Figure 13. Global Modified Proteomics Service Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Modified Proteomics Service Market Share by Application: 2025 VS 2032 Figure 15. Clinical Diagnostics Image Figure 16. Drug Discovery Image Figure 17. Others Image Figure 18. Global Modified Proteomics Service Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 19. Global Modified Proteomics Service Market Size (2021-2032) & (US$ Million) Figure 20. Global Modified Proteomics Service Market Share by Region: 2025 VS 2032 Figure 21. Years Considered Figure 22. Global Modified Proteomics Service Market Share by Players in 2025 Figure 23. Global Top 5 and 10 Modified Proteomics Service Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Global Modified Proteomics Service Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Modified Proteomics Service Revenue Market Share by Type (2021-2032) Figure 27. Global Modified Proteomics Service Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Modified Proteomics Service Revenue Market Share by Application (2021-2032) Figure 29. North America Modified Proteomics Service Market Size (2021-2032) & (US$ Million) Figure 30. North America Modified Proteomics Service Market Share by Type (2021-2032) Figure 31. North America Modified Proteomics Service Market Share by Application (2021-2032) Figure 32. North America Modified Proteomics Service Market Share by Country (2021-2032) Figure 33. United States Modified Proteomics Service Market Size (2021-2032) & (US$ Million) Figure 34. Canada Modified Proteomics Service Market Size (2021-2032) & (US$ Million) Figure 35. Mexico Modified Proteomics Service Market Size (2021-2032) & (US$ Million) Figure 36. Europe Modified Proteomics Service Market Size (2021-2032) & (US$ Million) Figure 37. Europe Modified Proteomics Service Market Share by Type (2021-2032) Figure 38. Europe Modified Proteomics Service Market Share by Application (2021-2032) Figure 39. Europe Modified Proteomics Service Market Share by Country (2021-2032) Figure 40. Germany Modified Proteomics Service Market Size (2021-2032) & (US$ Million) Figure 41. France Modified Proteomics Service Market Size (2021-2032) & (US$ Million) Figure 42. U.K. Modified Proteomics Service Market Size (2021-2032) & (US$ Million) Figure 43. Italy Modified Proteomics Service Market Size (2021-2032) & (US$ Million) Figure 44. Russia Modified Proteomics Service Market Size (2021-2032) & (US$ Million) Figure 45. Nordic Countries Modified Proteomics Service Market Size (2021-2032) & (US$ Million) Figure 46. China Modified Proteomics Service Market Size (2021-2032) & (US$ Million) Figure 47. China Modified Proteomics Service Market Share by Type (2021-2032) Figure 48. China Modified Proteomics Service Market Share by Application (2021-2032) Figure 49. Asia Modified Proteomics Service Market Size (2021-2032) & (US$ Million) Figure 50. Asia Modified Proteomics Service Market Share by Type (2021-2032) Figure 51. Asia Modified Proteomics Service Market Share by Application (2021-2032) Figure 52. Asia Modified Proteomics Service Market Share by Country (2021-2032) Figure 53. Japan Modified Proteomics Service Market Size (2021-2032) & (US$ Million) Figure 54. South Korea Modified Proteomics Service Market Size (2021-2032) & (US$ Million) Figure 55. Taiwan Modified Proteomics Service Market Size (2021-2032) & (US$ Million) Figure 56. Southeast Asia Modified Proteomics Service Market Size (2021-2032) & (US$ Million) Figure 57. India Modified Proteomics Service Market Size (2021-2032) & (US$ Million) Figure 58. Australia Modified Proteomics Service Market Size (2021-2032) & (US$ Million) Figure 59. South America, Middle East & Africa Modified Proteomics Service Market Size (2021-2032) & (US$ Million) Figure 60. South America, Middle East & Africa Modified Proteomics Service Market Share by Type (2021-2032) Figure 61. South America, Middle East & Africa Modified Proteomics Service Market Share by Application (2021-2032) Figure 62. South America, Middle East & Africa Modified Proteomics Service Market Share by Country (2021-2032) Figure 63. Brazil Modified Proteomics Service Market Size (2021-2032) & (US$ Million) Figure 64. South Africa Modified Proteomics Service Market Size (2021-2032) & (US$ Million) Figure 65. Saudi Arabia Modified Proteomics Service Market Size (2021-2032) & (US$ Million) Figure 66. Turkey Modified Proteomics Service Market Size (2021-2032) & (US$ Million) Figure 67. Argentina Modified Proteomics Service Market Size (2021-2032) & (US$ Million) Figure 68. UAE Modified Proteomics Service Market Size (2021-2032) & (US$ Million) Figure 69. Egypt Modified Proteomics Service Market Size (2021-2032) & (US$ Million) Figure 70. Chile Modified Proteomics Service Market Size (2021-2032) & (US$ Million) Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Phosphorylation
  • Acetylation
  • Ubiquitination
  • Methylation
  • Glycosylation
  • Lactylation
  • Redox
  • Palmitoylation
  • Others
Applications
  • Clinical Diagnostics
  • Drug Discovery
  • Others
Companies covered
  • BGI Genomics
  • OmicScouts (Momentum Biotechnologies)
  • Biodesix
  • Shanghai OE Biotech
  • Crown Bioscience
  • Shanghai Bioprofile
  • Creative Proteomics
  • Inotiv
  • MtoZ-Biolabs
  • CellCarta
  • Biognosys
  • MS Bioworks
  • Charles River Laboratories
  • Metware Biotechnology
  • Novogene
  • Evotec
  • RxCelerate
  • Shanghai Majorbio Bio-Pharm
  • Lc-Bio Technologies
  • CD Genomics
  • Discovery Life Sciences
  • Applied Biomics
  • VProteomics
  • Allumiqs
  • Westlake Omics
  • CDI Labs
  • Proteome Sciences
  • Sapient Bioanalytics
  • Proteomics International
  • Cosmos Wisdom
  • MRM Proteomics
  • Sinotech Genomics
  • Precision Biomarker Laboratories (PBL)
  • PTM BIO
  • Cell Signaling Technology (CST)
  • APTBIO

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Modified Proteomics Service Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Phosphorylation
  5. 1.2.3 Acetylation
  6. 1.2.4 Ubiquitination
  7. 1.2.5 Methylation
  8. 1.2.6 Glycosylation
  9. 1.2.7 Lactylation
  10. 1.2.8 Redox
  11. 1.2.9 Palmitoylation
  12. 1.2.10 Others
  13. 1.3 Market Analysis by Application
  14. 1.3.1 Global Modified Proteomics Service Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  15. 1.3.2 Clinical Diagnostics
  16. 1.3.3 Drug Discovery
  17. 1.3.4 Others
  18. 1.4 Global Market Growth Prospects
  19. 1.5 Global Modified Proteomics Service Growth Trends by Region
  20. 1.5.1 Global Modified Proteomics Service Market Size by Region: 2021 VS 2025 VS 2032
  21. 1.5.2 Modified Proteomics Service Market Size by Region (2021-2026)
  22. 1.5.3 Modified Proteomics Service Market Size by Region (2027-2032)
  23. 1.6 Assumptions and Limitations
  24. 1.7 Study Goals and Objectives
  25. 1.8 Years Considered
2 Global Modified Proteomics Service Market Dynamics
  1. 2.1 Modified Proteomics Service Industry Trends
  2. 2.2 Modified Proteomics Service Industry Drivers
  3. 2.3 Modified Proteomics Service Industry Opportunities and Challenges
  4. 2.4 Modified Proteomics Service Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Modified Proteomics Service Revenue by Company (2021-2026)
  2. 3.2 Global Modified Proteomics Service Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Modified Proteomics Service Key Company Head office and Area Served
  4. 3.4 Global Modified Proteomics Service Company, Product Type & Application
  5. 3.5 Global Modified Proteomics Service Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Modified Proteomics Service Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Modified Proteomics Service Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Modified Proteomics Service Tier 1, Tier 2, and Tier 3
4 Modified Proteomics Service Market by Type
  1. 4.1 Global Modified Proteomics Service Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Modified Proteomics Service Market Size by Type (2021-2032)
  3. 4.3 Global Modified Proteomics Service Market Size Share by Type (2021-2032)
5 Modified Proteomics Service Market by Application
  1. 5.1 Global Modified Proteomics Service Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Modified Proteomics Service Market Size by Application (2021-2032)
  3. 5.3 Global Modified Proteomics Service Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 BGI Genomics
  2. 6.1.1 BGI Genomics Company Information
  3. 6.1.2 BGI Genomics Business Overview
  4. 6.1.3 BGI Genomics Modified Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 BGI Genomics Modified Proteomics Service Product Portfolio
  6. 6.1.5 BGI Genomics Recent Developments
  7. 6.2 OmicScouts (Momentum Biotechnologies)
  8. 6.2.1 OmicScouts (Momentum Biotechnologies) Company Information
  9. 6.2.2 OmicScouts (Momentum Biotechnologies) Business Overview
  10. 6.2.3 OmicScouts (Momentum Biotechnologies) Modified Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 OmicScouts (Momentum Biotechnologies) Modified Proteomics Service Product Portfolio
  12. 6.2.5 OmicScouts (Momentum Biotechnologies) Recent Developments
  13. 6.3 Biodesix
  14. 6.3.1 Biodesix Company Information
  15. 6.3.2 Biodesix Business Overview
  16. 6.3.3 Biodesix Modified Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Biodesix Modified Proteomics Service Product Portfolio
  18. 6.3.5 Biodesix Recent Developments
  19. 6.4 Shanghai OE Biotech
  20. 6.4.1 Shanghai OE Biotech Company Information
  21. 6.4.2 Shanghai OE Biotech Business Overview
  22. 6.4.3 Shanghai OE Biotech Modified Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Shanghai OE Biotech Modified Proteomics Service Product Portfolio
  24. 6.4.5 Shanghai OE Biotech Recent Developments
  25. 6.5 Crown Bioscience
  26. 6.5.1 Crown Bioscience Company Information
  27. 6.5.2 Crown Bioscience Business Overview
  28. 6.5.3 Crown Bioscience Modified Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Crown Bioscience Modified Proteomics Service Product Portfolio
  30. 6.5.5 Crown Bioscience Recent Developments
  31. 6.6 Shanghai Bioprofile
  32. 6.6.1 Shanghai Bioprofile Company Information
  33. 6.6.2 Shanghai Bioprofile Business Overview
  34. 6.6.3 Shanghai Bioprofile Modified Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Shanghai Bioprofile Modified Proteomics Service Product Portfolio
  36. 6.6.5 Shanghai Bioprofile Recent Developments
  37. 6.7 Creative Proteomics
  38. 6.7.1 Creative Proteomics Company Information
  39. 6.7.2 Creative Proteomics Business Overview
  40. 6.7.3 Creative Proteomics Modified Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Creative Proteomics Modified Proteomics Service Product Portfolio
  42. 6.7.5 Creative Proteomics Recent Developments
  43. 6.8 Inotiv
  44. 6.8.1 Inotiv Company Information
  45. 6.8.2 Inotiv Business Overview
  46. 6.8.3 Inotiv Modified Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Inotiv Modified Proteomics Service Product Portfolio
  48. 6.8.5 Inotiv Recent Developments
  49. 6.9 MtoZ-Biolabs
  50. 6.9.1 MtoZ-Biolabs Company Information
  51. 6.9.2 MtoZ-Biolabs Business Overview
  52. 6.9.3 MtoZ-Biolabs Modified Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 MtoZ-Biolabs Modified Proteomics Service Product Portfolio
  54. 6.9.5 MtoZ-Biolabs Recent Developments
  55. 6.10 CellCarta
  56. 6.10.1 CellCarta Company Information
  57. 6.10.2 CellCarta Business Overview
  58. 6.10.3 CellCarta Modified Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 CellCarta Modified Proteomics Service Product Portfolio
  60. 6.10.5 CellCarta Recent Developments
  61. 6.11 Biognosys
  62. 6.11.1 Biognosys Company Information
  63. 6.11.2 Biognosys Business Overview
  64. 6.11.3 Biognosys Modified Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Biognosys Modified Proteomics Service Product Portfolio
  66. 6.11.5 Biognosys Recent Developments
  67. 6.12 MS Bioworks
  68. 6.12.1 MS Bioworks Company Information
  69. 6.12.2 MS Bioworks Business Overview
  70. 6.12.3 MS Bioworks Modified Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 MS Bioworks Modified Proteomics Service Product Portfolio
  72. 6.12.5 MS Bioworks Recent Developments
  73. 6.13 Charles River Laboratories
  74. 6.13.1 Charles River Laboratories Company Information
  75. 6.13.2 Charles River Laboratories Business Overview
  76. 6.13.3 Charles River Laboratories Modified Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 Charles River Laboratories Modified Proteomics Service Product Portfolio
  78. 6.13.5 Charles River Laboratories Recent Developments
  79. 6.14 Metware Biotechnology
  80. 6.14.1 Metware Biotechnology Company Information
  81. 6.14.2 Metware Biotechnology Business Overview
  82. 6.14.3 Metware Biotechnology Modified Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 Metware Biotechnology Modified Proteomics Service Product Portfolio
  84. 6.14.5 Metware Biotechnology Recent Developments
  85. 6.15 Novogene
  86. 6.15.1 Novogene Company Information
  87. 6.15.2 Novogene Business Overview
  88. 6.15.3 Novogene Modified Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  89. 6.15.4 Novogene Modified Proteomics Service Product Portfolio
  90. 6.15.5 Novogene Recent Developments
  91. 6.16 Evotec
  92. 6.16.1 Evotec Company Information
  93. 6.16.2 Evotec Business Overview
  94. 6.16.3 Evotec Modified Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  95. 6.16.4 Evotec Modified Proteomics Service Product Portfolio
  96. 6.16.5 Evotec Recent Developments
  97. 6.17 RxCelerate
  98. 6.17.1 RxCelerate Company Information
  99. 6.17.2 RxCelerate Business Overview
  100. 6.17.3 RxCelerate Modified Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  101. 6.17.4 RxCelerate Modified Proteomics Service Product Portfolio
  102. 6.17.5 RxCelerate Recent Developments
  103. 6.18 Shanghai Majorbio Bio-Pharm
  104. 6.18.1 Shanghai Majorbio Bio-Pharm Company Information
  105. 6.18.2 Shanghai Majorbio Bio-Pharm Business Overview
  106. 6.18.3 Shanghai Majorbio Bio-Pharm Modified Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  107. 6.18.4 Shanghai Majorbio Bio-Pharm Modified Proteomics Service Product Portfolio
  108. 6.18.5 Shanghai Majorbio Bio-Pharm Recent Developments
  109. 6.19 Lc-Bio Technologies
  110. 6.19.1 Lc-Bio Technologies Company Information
  111. 6.19.2 Lc-Bio Technologies Business Overview
  112. 6.19.3 Lc-Bio Technologies Modified Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  113. 6.19.4 Lc-Bio Technologies Modified Proteomics Service Product Portfolio
  114. 6.19.5 Lc-Bio Technologies Recent Developments
  115. 6.20 CD Genomics
  116. 6.20.1 CD Genomics Company Information
  117. 6.20.2 CD Genomics Business Overview
  118. 6.20.3 CD Genomics Modified Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  119. 6.20.4 CD Genomics Modified Proteomics Service Product Portfolio
  120. 6.20.5 CD Genomics Recent Developments
  121. 6.21 Discovery Life Sciences
  122. 6.21.1 Discovery Life Sciences Company Information
  123. 6.21.2 Discovery Life Sciences Business Overview
  124. 6.21.3 Discovery Life Sciences Modified Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  125. 6.21.4 Discovery Life Sciences Modified Proteomics Service Product Portfolio
  126. 6.21.5 Discovery Life Sciences Recent Developments
  127. 6.22 Applied Biomics
  128. 6.22.1 Applied Biomics Company Information
  129. 6.22.2 Applied Biomics Business Overview
  130. 6.22.3 Applied Biomics Modified Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  131. 6.22.4 Applied Biomics Modified Proteomics Service Product Portfolio
  132. 6.22.5 Applied Biomics Recent Developments
  133. 6.23 VProteomics
  134. 6.23.1 VProteomics Company Information
  135. 6.23.2 VProteomics Business Overview
  136. 6.23.3 VProteomics Modified Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  137. 6.23.4 VProteomics Modified Proteomics Service Product Portfolio
  138. 6.23.5 VProteomics Recent Developments
  139. 6.24 Allumiqs
  140. 6.24.1 Allumiqs Company Information
  141. 6.24.2 Allumiqs Business Overview
  142. 6.24.3 Allumiqs Modified Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  143. 6.24.4 Allumiqs Modified Proteomics Service Product Portfolio
  144. 6.24.5 Allumiqs Recent Developments
  145. 6.25 Westlake Omics
  146. 6.25.1 Westlake Omics Company Information
  147. 6.25.2 Westlake Omics Business Overview
  148. 6.25.3 Westlake Omics Modified Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  149. 6.25.4 Westlake Omics Modified Proteomics Service Product Portfolio
  150. 6.25.5 Westlake Omics Recent Developments
  151. 6.26 CDI Labs
  152. 6.26.1 CDI Labs Company Information
  153. 6.26.2 CDI Labs Business Overview
  154. 6.26.3 CDI Labs Modified Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  155. 6.26.4 CDI Labs Modified Proteomics Service Product Portfolio
  156. 6.26.5 CDI Labs Recent Developments
  157. 6.27 Proteome Sciences
  158. 6.27.1 Proteome Sciences Company Information
  159. 6.27.2 Proteome Sciences Business Overview
  160. 6.27.3 Proteome Sciences Modified Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  161. 6.27.4 Proteome Sciences Modified Proteomics Service Product Portfolio
  162. 6.27.5 Proteome Sciences Recent Developments
  163. 6.28 Sapient Bioanalytics
  164. 6.28.1 Sapient Bioanalytics Company Information
  165. 6.28.2 Sapient Bioanalytics Business Overview
  166. 6.28.3 Sapient Bioanalytics Modified Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  167. 6.28.4 Sapient Bioanalytics Modified Proteomics Service Product Portfolio
  168. 6.28.5 Sapient Bioanalytics Recent Developments
  169. 6.29 Proteomics International
  170. 6.29.1 Proteomics International Company Information
  171. 6.29.2 Proteomics International Business Overview
  172. 6.29.3 Proteomics International Modified Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  173. 6.29.4 Proteomics International Modified Proteomics Service Product Portfolio
  174. 6.29.5 Proteomics International Recent Developments
  175. 6.30 Cosmos Wisdom
  176. 6.30.1 Cosmos Wisdom Company Information
  177. 6.30.2 Cosmos Wisdom Business Overview
  178. 6.30.3 Cosmos Wisdom Modified Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  179. 6.30.4 Cosmos Wisdom Modified Proteomics Service Product Portfolio
  180. 6.30.5 Cosmos Wisdom Recent Developments
  181. 6.31 MRM Proteomics
  182. 6.31.1 MRM Proteomics Company Information
  183. 6.31.2 MRM Proteomics Business Overview
  184. 6.31.3 MRM Proteomics Modified Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  185. 6.31.4 MRM Proteomics Modified Proteomics Service Product Portfolio
  186. 6.31.5 MRM Proteomics Recent Developments
  187. 6.32 Sinotech Genomics
  188. 6.32.1 Sinotech Genomics Company Information
  189. 6.32.2 Sinotech Genomics Business Overview
  190. 6.32.3 Sinotech Genomics Modified Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  191. 6.32.4 Sinotech Genomics Modified Proteomics Service Product Portfolio
  192. 6.32.5 Sinotech Genomics Recent Developments
  193. 6.33 Precision Biomarker Laboratories (PBL)
  194. 6.33.1 Precision Biomarker Laboratories (PBL) Company Information
  195. 6.33.2 Precision Biomarker Laboratories (PBL) Business Overview
  196. 6.33.3 Precision Biomarker Laboratories (PBL) Modified Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  197. 6.33.4 Precision Biomarker Laboratories (PBL) Modified Proteomics Service Product Portfolio
  198. 6.33.5 Precision Biomarker Laboratories (PBL) Recent Developments
  199. 6.34 PTM BIO
  200. 6.34.1 PTM BIO Company Information
  201. 6.34.2 PTM BIO Business Overview
  202. 6.34.3 PTM BIO Modified Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  203. 6.34.4 PTM BIO Modified Proteomics Service Product Portfolio
  204. 6.34.5 PTM BIO Recent Developments
  205. 6.35 Cell Signaling Technology (CST)
  206. 6.35.1 Cell Signaling Technology (CST) Company Information
  207. 6.35.2 Cell Signaling Technology (CST) Business Overview
  208. 6.35.3 Cell Signaling Technology (CST) Modified Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  209. 6.35.4 Cell Signaling Technology (CST) Modified Proteomics Service Product Portfolio
  210. 6.35.5 Cell Signaling Technology (CST) Recent Developments
  211. 6.36 APTBIO
  212. 6.36.1 APTBIO Company Information
  213. 6.36.2 APTBIO Business Overview
  214. 6.36.3 APTBIO Modified Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  215. 6.36.4 APTBIO Modified Proteomics Service Product Portfolio
  216. 6.36.5 APTBIO Recent Developments
7 North America
  1. 7.1 North America Modified Proteomics Service Market Size (2021-2032)
  2. 7.2 North America Modified Proteomics Service Market Size by Type
  3. 7.2.1 North America Modified Proteomics Service Market Size by Type (2021-2026)
  4. 7.2.2 North America Modified Proteomics Service Market Size by Type (2027-2032)
  5. 7.2.3 North America Modified Proteomics Service Market Share by Type (2021-2032)
  6. 7.3 North America Modified Proteomics Service Market Size by Application
  7. 7.3.1 North America Modified Proteomics Service Market Size by Application (2021-2026)
  8. 7.3.2 North America Modified Proteomics Service Market Size by Application (2027-2032)
  9. 7.3.3 North America Modified Proteomics Service Market Share by Application (2021-2032)
  10. 7.4 North America Modified Proteomics Service Market Size by Country
  11. 7.4.1 North America Modified Proteomics Service Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Modified Proteomics Service Market Size by Country (2021-2026)
  13. 7.4.3 North America Modified Proteomics Service Market Size by Country (2027-2032)
  14. 7.4.4 North America Modified Proteomics Service Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Modified Proteomics Service Market Size (2021-2032)
  2. 8.2 Europe Modified Proteomics Service Market Size by Type
  3. 8.2.1 Europe Modified Proteomics Service Market Size by Type (2021-2026)
  4. 8.2.2 Europe Modified Proteomics Service Market Size by Type (2027-2032)
  5. 8.2.3 Europe Modified Proteomics Service Market Share by Type (2021-2032)
  6. 8.3 Europe Modified Proteomics Service Market Size by Application
  7. 8.3.1 Europe Modified Proteomics Service Market Size by Application (2021-2026)
  8. 8.3.2 Europe Modified Proteomics Service Market Size by Application (2027-2032)
  9. 8.3.3 Europe Modified Proteomics Service Market Share by Application (2021-2032)
  10. 8.4 Europe Modified Proteomics Service Market Size by Country
  11. 8.4.1 Europe Modified Proteomics Service Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Modified Proteomics Service Market Size by Country (2021-2026)
  13. 8.4.3 Europe Modified Proteomics Service Market Size by Country (2027-2032)
  14. 8.4.4 Europe Modified Proteomics Service Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Modified Proteomics Service Market Size (2021-2032)
  2. 9.2 China Modified Proteomics Service Market Size by Type
  3. 9.2.1 China Modified Proteomics Service Market Size by Type (2021-2026)
  4. 9.2.2 China Modified Proteomics Service Market Size by Type (2027-2032)
  5. 9.2.3 China Modified Proteomics Service Market Share by Type (2021-2032)
  6. 9.3 China Modified Proteomics Service Market Size by Application
  7. 9.3.1 China Modified Proteomics Service Market Size by Application (2021-2026)
  8. 9.3.2 China Modified Proteomics Service Market Size by Application (2027-2032)
  9. 9.3.3 China Modified Proteomics Service Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Modified Proteomics Service Market Size (2021-2032)
  2. 10.2 Asia Modified Proteomics Service Market Size by Type
  3. 10.2.1 Asia Modified Proteomics Service Market Size by Type (2021-2026)
  4. 10.2.2 Asia Modified Proteomics Service Market Size by Type (2027-2032)
  5. 10.2.3 Asia Modified Proteomics Service Market Share by Type (2021-2032)
  6. 10.3 Asia Modified Proteomics Service Market Size by Application
  7. 10.3.1 Asia Modified Proteomics Service Market Size by Application (2021-2026)
  8. 10.3.2 Asia Modified Proteomics Service Market Size by Application (2027-2032)
  9. 10.3.3 Asia Modified Proteomics Service Market Share by Application (2021-2032)
  10. 10.4 Asia Modified Proteomics Service Market Size by Country
  11. 10.4.1 Asia Modified Proteomics Service Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Modified Proteomics Service Market Size by Country (2021-2026)
  13. 10.4.3 Asia Modified Proteomics Service Market Size by Country (2027-2032)
  14. 10.4.4 Asia Modified Proteomics Service Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Modified Proteomics Service Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Modified Proteomics Service Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Modified Proteomics Service Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Modified Proteomics Service Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Modified Proteomics Service Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Modified Proteomics Service Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Modified Proteomics Service Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Modified Proteomics Service Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Modified Proteomics Service Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Modified Proteomics Service Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Modified Proteomics Service Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Modified Proteomics Service Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Modified Proteomics Service Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Modified Proteomics Service Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst